Galapagos | Costo Del Venduto



Cost Of Sales Cambiamento Data
argenx SE USD 110.75M 29.94M 2025-06
AstraZeneca USD 2.47B 232M 2025-06
Biogen USD 605M 24.3M 2025-06
Genmab DKK 57M 15M 2025-06
Gilead Sciences USD 1.5B 39M 2025-06
GlaxoSmithKline GBP 2.16B 241M 2025-06
GRIFOLS EUR 1.15B 56.19M 2025-06
Hikma Pharmaceutical USD 895M 82M 2024-12
Incyte USD 78.77M 10.96M 2025-06
Merck EUR 2.23B 93M 2025-06
Neurocrine Biosciences USD 11.3M 2.1M 2025-06
Novartis USD 3.32B 95M 2025-06
Roche Holding CHF 4.13B 393.5M 2024-12
Sanofi EUR 2.99B 103M 2025-06
UCB EUR 901M 50M 2024-12
Vertex Pharmaceuticals USD 407.5M 44.5M 2025-06


Galapagos Costo Del Venduto - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Aug 2025.